magnesium sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4290 7487-88-9

Description:

MoleculeDescription

Synonyms:

  • magnesium sulfate
  • sulfuric acid magnesium salt
  • epsom salt
  • magnesium sulphate
  • magnesium sulfate heptahydrate
  • magnesium sulfate, unspecified
  • magnesium sulfate anhydrous
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
  • Molecular weight: 120.36
  • Formula: MgO4S
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
7 g O
3 g O

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Oct. 6, 1981 FDA BAXTER HLTHCARE
Jan. 22, 2021 PMDA NIHON PHARMACEUTICAL CO., LTD.

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Premature delivery 319.89 10.26 262 67238 30019 63391503
Macular degeneration 298.37 10.26 230 67270 24146 63397376
Normal labour 245.82 10.26 65 67435 452 63421070
Delivery 185.65 10.26 66 67434 1337 63420185
Contraindicated product administered 170.35 10.26 17 67483 217631 63203891
Premature baby 169.48 10.26 155 67345 20580 63400942
Synovitis 159.10 10.26 10 67490 186908 63234614
Systemic lupus erythematosus 156.71 10.26 19 67481 208899 63212623
Hypermagnesaemia 155.99 10.26 53 67447 933 63420589
Hand deformity 154.63 10.26 3 67497 159454 63262068
Treatment failure 140.08 10.26 22 67478 199021 63222501
Exposure during pregnancy 135.45 10.26 418 67082 155129 63266393
Completed suicide 129.54 10.26 6 67494 145667 63275855
Glossodynia 127.63 10.26 19 67481 178857 63242665
Drug intolerance 112.12 10.26 98 67402 308563 63112959
Pericarditis 109.13 10.26 8 67492 131571 63289951
Pulmonary oedema 107.37 10.26 202 67298 54671 63366851
Arthropathy 107.25 10.26 58 67442 234734 63186788
Product use issue 102.89 10.26 53 67447 220467 63201055
Wound 96.50 10.26 27 67473 163236 63258286
Joint swelling 94.60 10.26 126 67374 327540 63093982
PCO2 increased 94.46 10.26 39 67461 1200 63420322
Paraesthesia oral 93.81 10.26 109 67391 19147 63402375
Therapeutic product effect decreased 84.93 10.26 50 67450 193137 63228385
Blood pH decreased 80.75 10.26 44 67456 2543 63418979
Rheumatoid arthritis 76.95 10.26 94 67406 253725 63167797
Maternal exposure during pregnancy 76.69 10.26 447 67053 219615 63201907
Duodenal ulcer perforation 76.20 10.26 4 67496 87205 63334317
Low birth weight baby 73.81 10.26 61 67439 7068 63414454
Chronic sinusitis 71.61 10.26 78 67422 12765 63408757
Postpartum haemorrhage 71.16 10.26 37 67463 1944 63419578
Blood bicarbonate decreased 70.24 10.26 42 67458 2899 63418623
Propofol infusion syndrome 68.42 10.26 29 67471 954 63420568
Mitochondrial DNA mutation 68.00 10.26 23 67477 399 63421123
Lower respiratory tract infection 65.97 10.26 29 67471 132278 63289244
Diabetes insipidus 64.03 10.26 38 67462 2587 63418935
Renal ischaemia 62.46 10.26 24 67476 609 63420913
Discomfort 60.87 10.26 53 67447 167321 63254201
Folliculitis 59.09 10.26 4 67496 70313 63351209
Toxicity to various agents 58.98 10.26 108 67392 247142 63174380
Procedural pain 58.78 10.26 92 67408 21477 63400045
Drug abuse 58.46 10.26 5 67495 72513 63349009
Hepatic enzyme increased 58.12 10.26 78 67422 202250 63219272
Alopecia 57.01 10.26 177 67323 337359 63084163
Hypersensitivity 55.66 10.26 145 67355 292540 63128982
Foetal exposure during pregnancy 52.07 10.26 109 67391 31853 63389669
Unevaluable event 51.23 10.26 145 67355 51241 63370281
PO2 increased 48.43 10.26 22 67478 857 63420665
Cytokine release syndrome 47.55 10.26 67 67433 14247 63407275
Arthralgia 47.52 10.26 383 67117 569327 62852195
Diarrhoea 45.64 10.26 1037 66463 714329 62707193
Intentional product use issue 44.70 10.26 42 67458 127850 63293672
Vaginal flatulence 44.54 10.26 33 67467 3260 63418262
Irritable bowel syndrome 44.45 10.26 16 67484 82396 63339126
Drug hypersensitivity 44.32 10.26 175 67325 310512 63111010
Blood gases abnormal 44.08 10.26 20 67480 777 63420745
Neonatal intestinal perforation 41.82 10.26 9 67491 21 63421501
Abdominal discomfort 40.71 10.26 189 67311 320696 63100826
Gene mutation 40.34 10.26 24 67476 1641 63419881
Helicobacter infection 39.37 10.26 25 67475 92760 63328762
Swelling 39.34 10.26 155 67345 275223 63146299
CSF oligoclonal band present 38.87 10.26 15 67485 385 63421137
Foetal death 38.87 10.26 53 67447 10927 63410595
Pre-eclampsia 38.43 10.26 48 67452 9085 63412437
Blood magnesium decreased 38.36 10.26 58 67442 13140 63408382
C-reactive protein abnormal 37.64 10.26 3 67497 46093 63375429
Ill-defined disorder 36.12 10.26 21 67479 81734 63339788
Acute respiratory failure 36.03 10.26 99 67401 34386 63387136
Blister 35.31 10.26 52 67448 129762 63291760
Hypomagnesaemia 34.62 10.26 87 67413 28650 63392872
Intentional overdose 34.28 10.26 18 67482 74134 63347388
Muscle spasms 34.06 10.26 283 67217 155867 63265655
Proctitis 33.80 10.26 35 67465 5406 63416116
Neonatal respiratory distress syndrome 33.18 10.26 26 67474 2792 63418730
Deep vein thrombosis 32.29 10.26 175 67325 83625 63337897
Colitis 32.08 10.26 119 67381 48409 63373113
Impaired healing 32.08 10.26 37 67463 102505 63319017
Airway peak pressure increased 32.05 10.26 12 67488 283 63421239
Caesarean section 31.21 10.26 61 67439 16971 63404551
COVID-19 31.06 10.26 45 67455 113058 63308464
Blood lactic acid increased 31.03 10.26 38 67462 7048 63414474
Musculoskeletal stiffness 30.99 10.26 97 67403 184521 63237001
Gastrointestinal disorder 30.67 10.26 58 67442 131181 63290341
Neuropathy peripheral 30.36 10.26 216 67284 113451 63308071
Hypotension 30.01 10.26 431 67069 272173 63149349
Device expulsion 29.55 10.26 93 67407 34829 63386693
Full blood count decreased 29.50 10.26 77 67423 25947 63395575
Blood magnesium increased 29.39 10.26 25 67475 3013 63418509
Suicide attempt 29.34 10.26 14 67486 60904 63360618
Female genital tract fistula 29.08 10.26 38 67462 7521 63414001
Neuromuscular blockade 28.34 10.26 11 67489 287 63421235
Pleocytosis 28.13 10.26 15 67485 830 63420692
Oxygen saturation abnormal 28.09 10.26 26 67474 3503 63418019
Respiratory failure 28.04 10.26 195 67305 101663 63319859
Vaginal discharge 27.55 10.26 41 67459 9157 63412365
Liver injury 27.52 10.26 15 67485 60505 63361017
Maternal exposure during delivery 27.22 10.26 18 67482 1482 63420040
Lung hyperinflation 27.11 10.26 17 67483 1278 63420244
Radiculopathy 26.68 10.26 39 67461 8572 63412950
Apgar score low 26.33 10.26 14 67486 770 63420752
Respiratory acidosis 26.21 10.26 34 67466 6681 63414841
Device dislocation 26.07 10.26 73 67427 25632 63395890
Product dose omission issue 25.99 10.26 371 67129 233942 63187580
Condition aggravated 25.93 10.26 288 67212 401929 63019593
Neuromuscular block prolonged 25.01 10.26 12 67488 530 63420992
Vaginal haemorrhage 24.93 10.26 75 67425 27412 63394110
Hypervolaemia 24.34 10.26 76 67424 28337 63393185
Urticaria thermal 24.23 10.26 11 67489 428 63421094
General physical health deterioration 24.13 10.26 121 67379 201281 63220241
Therapy cessation 23.86 10.26 79 67421 30378 63391144
Anaemia 23.74 10.26 441 67059 292989 63128533
Craniotabes 23.39 10.26 4 67496 0 63421522
Dehydration 22.74 10.26 283 67217 173071 63248451
HELLP syndrome 22.60 10.26 14 67486 1030 63420492
Pneumonia 22.46 10.26 640 66860 456127 62965395
PO2 decreased 22.43 10.26 16 67484 1490 63420032
Premature labour 21.96 10.26 44 67456 12460 63409062
Encephalopathy 21.71 10.26 90 67410 38530 63382992
Asthma 21.41 10.26 67 67433 127494 63294028
Neonatal gastrointestinal haemorrhage 21.21 10.26 5 67495 20 63421502
Infection 19.99 10.26 152 67348 229021 63192501
Hypoxia 19.84 10.26 120 67380 59672 63361850
Foetal heart rate deceleration abnormality 19.71 10.26 10 67490 499 63421023
Sepsis 19.67 10.26 249 67251 152874 63268648
Dyspepsia 19.56 10.26 180 67320 102016 63319506
Infusion related reaction 19.51 10.26 167 67333 245354 63176168
Hypocalcaemia 19.50 10.26 76 67424 31637 63389885
Status asthmaticus 19.26 10.26 12 67488 892 63420630
Hypercapnia 18.90 10.26 26 67474 5405 63416117
Plasma cell myeloma 18.88 10.26 82 67418 35823 63385699
Pain 18.71 10.26 623 66877 740005 62681517
Constipation 18.50 10.26 339 67161 224604 63196918
Pelvic pain 18.50 10.26 43 67457 13476 63408046
Administration site erythema 18.46 10.26 11 67489 754 63420768
Acute pulmonary oedema 18.45 10.26 32 67468 8126 63413396
Neonatal disorder 18.43 10.26 10 67490 573 63420949
Nausea 18.04 10.26 1094 66406 853377 62568145
Infantile apnoea 17.79 10.26 12 67488 1021 63420501
Psoriasis 17.58 10.26 155 67345 86802 63334720
Foetal growth restriction 17.57 10.26 30 67470 7523 63413999
Hypokalaemia 17.48 10.26 178 67322 103626 63317896
Hip arthroplasty 17.41 10.26 15 67485 47631 63373891
Left ventricular dysfunction 17.37 10.26 39 67461 11949 63409573
Skin discolouration 17.37 10.26 83 67417 37745 63383777
Blood potassium decreased 17.02 10.26 89 67411 41937 63379585
Intentional product misuse 16.95 10.26 24 67476 60893 63360629
Off label use 16.86 10.26 568 66932 673894 62747628
Weight increased 16.67 10.26 187 67313 260605 63160917
Chills 16.58 10.26 189 67311 113189 63308333
Frequent bowel movements 16.52 10.26 58 67442 22964 63398558
Loss of personal independence in daily activities 16.39 10.26 51 67449 97239 63324283
Dizziness 16.30 10.26 584 66916 429341 62992181
Fear 16.21 10.26 45 67455 15721 63405801
Delayed fontanelle closure 16.08 10.26 4 67496 21 63421501
Rectal haemorrhage 16.01 10.26 98 67402 48932 63372590
Atrial fibrillation 15.98 10.26 192 67308 116444 63305078
Red blood cell sedimentation rate increased 15.89 10.26 14 67486 43968 63377554
Myelosuppression 15.82 10.26 3 67497 23700 63397822
Neonatal infection 15.81 10.26 6 67494 147 63421375
Nail bed tenderness 15.73 10.26 8 67492 401 63421121
C-reactive protein increased 15.71 10.26 50 67450 94657 63326865
Intentional self-injury 15.63 10.26 4 67496 25683 63395839
Drug interaction 15.57 10.26 162 67338 228969 63192553
Osteonecrosis of jaw 15.54 10.26 9 67491 35114 63386408
Normal newborn 15.43 10.26 30 67470 8311 63413211
Blood calcium decreased 15.15 10.26 62 67438 26389 63395133
Flatulence 15.11 10.26 75 67425 34627 63386895
Platelet count decreased 14.98 10.26 189 67311 115933 63305589
Product compounding quality issue 14.86 10.26 4 67496 30 63421492
Nasopharyngitis 14.84 10.26 186 67314 254071 63167451
Immune effector cell-associated neurotoxicity syndrome 14.78 10.26 15 67485 2262 63419260
Asthenia 14.76 10.26 522 66978 383082 63038440
Ventricular extrasystoles 14.73 10.26 36 67464 11651 63409871
Laboratory test abnormal 14.57 10.26 62 67438 26850 63394672
Therapeutic response decreased 14.53 10.26 27 67473 61498 63360024
Haemoglobin decreased 14.41 10.26 226 67274 145259 63276263
Clonus 14.37 10.26 21 67479 4615 63416907
Pleural effusion 14.36 10.26 157 67343 93053 63328469
Vitamin B6 increased 14.12 10.26 4 67496 37 63421485
Abdominal distension 13.86 10.26 147 67353 86468 63335054
Overdose 13.85 10.26 69 67431 115009 63306513
Anaphylactic shock 13.78 10.26 4 67496 23629 63397893
Knee arthroplasty 13.51 10.26 23 67477 54183 63367339
Electroencephalogram abnormal 13.42 10.26 18 67482 3654 63417868
Cystitis-like symptom 13.39 10.26 3 67497 9 63421513
Device related sepsis 13.35 10.26 19 67481 4075 63417447
Endometritis 13.32 10.26 10 67490 1008 63420514
Abdominal pain 13.25 10.26 407 67093 293049 63128473
Blood pressure fluctuation 13.14 10.26 18 67482 46299 63375223
Bursitis 13.13 10.26 12 67488 37029 63384493
Weight decreased 13.07 10.26 386 67114 276412 63145110
Feeling abnormal 13.03 10.26 226 67274 148166 63273356
Patent ductus arteriosus 12.81 10.26 19 67481 4231 63417291
Pulmonary hypertension 12.63 10.26 75 67425 37048 63384474
Drug ineffective 12.44 10.26 950 66550 1043815 62377707
Intestinal dilatation 12.39 10.26 12 67488 1710 63419812
Mobility decreased 12.21 10.26 77 67423 121082 63300440
Mental status changes 12.21 10.26 78 67422 39521 63382001
Blood albumin decreased 12.19 10.26 39 67461 14727 63406795
Osmotic demyelination syndrome 12.14 10.26 8 67492 655 63420867
Coma 12.12 10.26 32 67468 64332 63357190
Joint range of motion decreased 12.10 10.26 10 67490 32418 63389104
Pancreatitis chronic 11.99 10.26 14 67486 2470 63419052
Drug reaction with eosinophilia and systemic symptoms 11.94 10.26 11 67489 33825 63387697
Emotional distress 11.88 10.26 67 67433 32482 63389040
Fall 11.84 10.26 520 66980 391814 63029708
Adverse event 11.68 10.26 35 67465 67524 63353998
Antinuclear antibody positive 11.56 10.26 26 67474 7973 63413549
Interstitial lung disease 11.49 10.26 31 67469 61877 63359645
Myasthenia gravis crisis 11.42 10.26 7 67493 505 63421017
Inflammation 11.29 10.26 47 67453 82226 63339296
Blood culture positive 11.27 10.26 19 67481 4716 63416806
Urine output decreased 11.24 10.26 32 67468 11338 63410184
Blood pressure systolic increased 11.02 10.26 21 67479 47376 63374146
Fibromyalgia 11.00 10.26 46 67454 80374 63341148
Fallot's tetralogy 10.99 10.26 4 67496 87 63421435
Vulvovaginal swelling 10.95 10.26 7 67493 544 63420978
Hypoaesthesia 10.92 10.26 245 67255 168148 63253374
Grip strength decreased 10.92 10.26 5 67495 22282 63399240
Flushing 10.90 10.26 125 67375 74962 63346560
Hepatitis 10.75 10.26 16 67484 39772 63381750
Diastolic hypotension 10.74 10.26 4 67496 93 63421429
Pulmonary valve incompetence 10.64 10.26 10 67490 1373 63420149
Rhabdomyolysis 10.64 10.26 19 67481 43932 63377590
Plasma cell myeloma recurrent 10.61 10.26 15 67485 3198 63418324
Hypoventilation neonatal 10.57 10.26 3 67497 28 63421494
Eclampsia 10.56 10.26 6 67494 376 63421146
Vascular resistance systemic decreased 10.54 10.26 4 67496 98 63421424
Hypophagia 10.53 10.26 63 67437 31196 63390326
Colitis ulcerative 10.39 10.26 55 67445 26036 63395486
Lethargy 10.38 10.26 98 67402 55909 63365613
Diabetes mellitus 10.32 10.26 28 67472 55782 63365740
Obesity 10.27 10.26 10 67490 29942 63391580

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Premature baby 106.20 10.59 122 40210 19511 34897088
Adrenal suppression 85.28 10.59 31 40301 616 34915983
Drug abuse 80.10 10.59 10 40322 99086 34817513
Completed suicide 76.74 10.59 11 40321 98157 34818442
Cytokine release syndrome 74.92 10.59 111 40221 22766 34893833
Gingival disorder 60.45 10.59 31 40301 1456 34915143
Toxicity to various agents 59.41 10.59 87 40245 200275 34716324
Off label use 55.25 10.59 273 40059 419251 34497348
Low birth weight baby 47.66 10.59 52 40280 7853 34908746
Skin irritation 45.13 10.59 43 40289 5534 34911065
Tachycardia foetal 39.92 10.59 15 40317 328 34916271
Drug interaction 39.07 10.59 132 40200 225814 34690785
Immune effector cell-associated neurotoxicity syndrome 38.67 10.59 33 40299 3680 34912919
Intentional product misuse 38.35 10.59 4 40328 45607 34870992
Product use in unapproved indication 35.79 10.59 50 40282 117449 34799150
Oral disorder 32.94 10.59 32 40300 4217 34912382
Drug ineffective 32.92 10.59 353 39979 456398 34460201
Plasma cell myeloma 32.84 10.59 115 40217 41922 34874677
Foetal exposure during pregnancy 30.43 10.59 105 40227 37996 34878603
Unevaluable event 29.77 10.59 94 40238 32496 34884103
Apgar score low 28.88 10.59 16 40316 879 34915720
Respiratory disorder 28.08 10.59 66 40266 19198 34897401
Pneumonia 27.83 10.59 579 39753 362048 34554551
General physical health deterioration 27.19 10.59 68 40264 128201 34788398
Blood potassium decreased 26.80 10.59 62 40270 17853 34898746
Foetal distress syndrome 25.82 10.59 16 40316 1084 34915515
Sleep disorder due to a general medical condition 25.82 10.59 31 40301 5190 34911409
Diarrhoea 24.72 10.59 606 39726 389306 34527293
Overdose 24.60 10.59 42 40290 91017 34825582
Fatigue 24.37 10.59 579 39753 370074 34546525
Suicide attempt 23.31 10.59 8 40324 39108 34877491
Intentional overdose 22.67 10.59 11 40321 43663 34872936
Asthenia 22.65 10.59 403 39929 244848 34671751
Hypermagnesaemia 22.12 10.59 9 40323 245 34916354
Burkholderia test positive 21.81 10.59 14 40318 1009 34915590
Small intestinal obstruction 21.74 10.59 51 40281 14815 34901784
Laboratory test abnormal 21.62 10.59 62 40270 20329 34896270
Fall 20.76 10.59 339 39993 202546 34714053
Hypoxia 19.86 10.59 120 40212 54975 34861624
Anhedonia 19.56 10.59 33 40299 7552 34909047
Product use issue 19.13 10.59 27 40305 63189 34853410
White blood cell count decreased 19.13 10.59 181 40151 95264 34821335
Respiratory tract infection bacterial 18.89 10.59 16 40316 1766 34914833
Fear 18.78 10.59 39 40293 10437 34906162
Intentional product use issue 18.65 10.59 25 40307 59791 34856808
Full blood count decreased 18.22 10.59 54 40278 18034 34898565
Injury 17.38 10.59 58 40274 20629 34895970
Adrenal insufficiency 17.17 10.59 45 40287 14002 34902597
Lip swelling 17.15 10.59 49 40283 16031 34900568
Dehydration 17.15 10.59 227 40105 129742 34786857
Constipation 16.75 10.59 236 40096 136746 34779853
Complication of device removal 16.55 10.59 5 40327 54 34916545
Mental status changes 16.39 10.59 87 40245 37996 34878603
Viral infection 16.24 10.59 51 40281 17572 34899027
Bradycardia foetal 16.00 10.59 8 40324 356 34916243
Foetal heart rate deceleration abnormality 15.96 10.59 9 40323 512 34916087
Bronchiectasis 15.86 10.59 35 40297 9766 34906833
Product contamination 15.69 10.59 10 40322 712 34915887
Sepsis 15.45 10.59 274 40058 166287 34750312
Platelet count decreased 15.34 10.59 208 40124 119509 34797090
Rhabdomyolysis 15.33 10.59 35 40297 68128 34848471
Rheumatoid arthritis 15.25 10.59 13 40319 38225 34878374
Condition aggravated 15.22 10.59 145 40187 192051 34724548
Treatment failure 15.09 10.59 19 40313 46678 34869921
Caesarean section 14.40 10.59 15 40317 2149 34914450
Drug resistance 14.28 10.59 6 40326 25921 34890678
Respiratory tract infection viral 14.21 10.59 16 40316 2501 34914098
Renal injury 13.82 10.59 36 40296 11159 34905440
Acute respiratory failure 13.55 10.59 71 40261 30857 34885742
Behaviour disorder 13.52 10.59 22 40310 4888 34911711
Contraindicated product administered 13.49 10.59 4 40328 21477 34895122
Splenic vein thrombosis 13.38 10.59 8 40324 508 34916091
Coma 13.34 10.59 20 40312 45658 34870941
Adverse drug reaction 12.61 10.59 67 40265 29275 34887324
Neuropathy peripheral 12.50 10.59 149 40183 83114 34833485
Agranulocytosis 12.36 10.59 6 40326 23815 34892784
Back pain 12.25 10.59 203 40129 121586 34795013
Pantoea agglomerans infection 12.17 10.59 4 40328 58 34916541
Hypervolaemia 12.15 10.59 50 40282 19659 34896940
Patent ductus arteriosus 12.03 10.59 17 40315 3337 34913262
Mixed dementia 11.89 10.59 6 40326 272 34916327
Oesophagitis 11.88 10.59 38 40294 13223 34903376
Anorgasmia 11.87 10.59 9 40323 848 34915751
Product dose omission issue 11.84 10.59 199 40133 119512 34797087
Blood magnesium decreased 11.62 10.59 24 40308 6399 34910200
Metabolic encephalopathy 11.50 10.59 19 40313 4273 34912326
Ureteric stenosis 11.33 10.59 10 40322 1166 34915433
Maternal drugs affecting foetus 11.23 10.59 18 40314 3947 34912652
Intraventricular haemorrhage neonatal 11.22 10.59 6 40326 307 34916292
Catheter site related reaction 11.13 10.59 6 40326 312 34916287
Apnoea 11.01 10.59 24 40308 6640 34909959
Hepatocellular injury 10.92 10.59 6 40326 22205 34894394
Transverse presentation 10.84 10.59 4 40328 83 34916516

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Completed suicide 200.14 9.67 16 84484 245751 79414137
Premature delivery 177.94 9.67 168 84332 23299 79636589
Exposure during pregnancy 145.25 9.67 327 84173 100805 79559083
Synovitis 137.55 9.67 5 84495 150729 79509159
Toxicity to various agents 123.93 9.67 159 84341 421381 79238507
Drug abuse 123.39 9.67 14 84486 162677 79497211
Cytokine release syndrome 116.36 9.67 166 84334 35832 79624056
Contraindicated product administered 108.97 9.67 18 84482 157520 79502368
Hypermagnesaemia 108.18 9.67 43 84457 1201 79658687
Drug intolerance 101.18 9.67 79 84421 264040 79395848
Hand deformity 92.92 9.67 4 84496 103915 79555973
Macular degeneration 89.73 9.67 83 84417 11213 79648675
Treatment failure 86.71 9.67 36 84464 170450 79489438
PCO2 increased 82.81 9.67 40 84460 1800 79658088
Systemic lupus erythematosus 81.25 9.67 15 84485 121134 79538754
Paraesthesia oral 80.75 9.67 104 84396 20367 79639521
Joint swelling 77.61 9.67 116 84384 288530 79371358
Product use issue 71.57 9.67 70 84430 209752 79450136
Blood pH decreased 67.92 9.67 49 84451 4662 79655226
Product use in unapproved indication 67.89 9.67 100 84400 250259 79409629
Mitochondrial DNA mutation 67.50 9.67 23 84477 410 79659478
Arthropathy 65.27 9.67 55 84445 177056 79482832
Chronic sinusitis 64.09 9.67 74 84426 12952 79646936
Procedural pain 63.90 9.67 99 84401 22985 79636903
Rheumatoid arthritis 60.79 9.67 79 84421 208391 79451497
Diabetes insipidus 58.97 9.67 47 84453 5190 79654698
Unevaluable event 58.85 9.67 160 84340 55425 79604463
Intentional product use issue 58.85 9.67 45 84455 152067 79507821
Pericarditis 58.06 9.67 19 84481 104217 79555671
Drug interaction 57.21 9.67 236 84264 414947 79244941
Maternal exposure during pregnancy 54.38 9.67 287 84213 136251 79523637
Glossodynia 53.87 9.67 21 84479 103316 79556572
Propofol infusion syndrome 51.87 9.67 30 84470 1953 79657935
Intentional product misuse 51.86 9.67 18 84482 95147 79564741
Blood bicarbonate decreased 50.93 9.67 43 84457 5148 79654740
Foetal death 50.57 9.67 52 84448 7992 79651896
Vaginal flatulence 49.52 9.67 32 84468 2543 79657345
Duodenal ulcer perforation 49.43 9.67 6 84494 66205 79593683
Hepatic enzyme increased 49.42 9.67 73 84427 182537 79477351
Renal ischaemia 48.51 9.67 24 84476 1138 79658750
Helicobacter infection 48.11 9.67 8 84492 69696 79590192
Therapeutic product effect decreased 47.86 9.67 62 84438 163801 79496087
Pulmonary oedema 47.15 9.67 202 84298 88052 79571836
General physical health deterioration 46.87 9.67 143 84357 275095 79384793
Acute respiratory failure 46.57 9.67 154 84346 59387 79600501
Pneumonia 46.36 9.67 968 83532 659278 79000610
Pre-eclampsia 45.14 9.67 46 84454 6995 79652893
Off label use 44.64 9.67 685 83815 906530 78753358
Blood magnesium decreased 44.57 9.67 70 84430 16442 79643446
Intentional overdose 44.06 9.67 29 84471 105931 79553957
Arthralgia 43.48 9.67 392 84108 571411 79088477
Diarrhoea 42.62 9.67 1227 83273 879262 78780626
Hypoxia 41.09 9.67 217 84283 103026 79556862
Device expulsion 40.93 9.67 87 84413 25774 79634114
Immune effector cell-associated neurotoxicity syndrome 40.80 9.67 40 84460 5808 79654080
Hypomagnesaemia 40.01 9.67 125 84375 46786 79613102
Muscle injury 39.94 9.67 3 84497 48558 79611330
Suicide attempt 39.81 9.67 19 84481 82913 79576975
Dehydration 39.76 9.67 420 84080 247767 79412121
Hypervolaemia 39.45 9.67 117 84383 42573 79617315
Folliculitis 39.02 9.67 6 84494 55374 79604514
Lower respiratory tract infection 38.66 9.67 48 84452 129172 79530716
Wound 38.18 9.67 40 84460 116139 79543749
CSF oligoclonal band present 38.18 9.67 15 84485 406 79659482
Blood potassium decreased 37.90 9.67 122 84378 46390 79613498
Plasma cell myeloma 37.49 9.67 133 84367 53126 79606762
Deep vein thrombosis 36.96 9.67 237 84263 120682 79539206
Blood gases abnormal 36.70 9.67 20 84480 1160 79658728
PO2 increased 36.24 9.67 22 84478 1566 79658322
Fear 36 9.67 75 84425 21911 79637977
Mental status changes 35.56 9.67 153 84347 66806 79593082
Hypotension 34.32 9.67 656 83844 439661 79220227
Therapeutic response decreased 34.16 9.67 14 84486 66839 79593049
Overdose 34.05 9.67 92 84408 184114 79475774
Respiratory failure 33.73 9.67 316 84184 180595 79479293
Product dose omission issue 32.92 9.67 404 84096 247133 79412755
Female genital tract fistula 32.91 9.67 36 84464 5939 79653949
Vaginal discharge 32.75 9.67 40 84460 7423 79652465
Sepsis 31.73 9.67 430 84070 268998 79390890
Hepatocellular injury 31.67 9.67 6 84494 47587 79612301
Condition aggravated 31.65 9.67 359 84141 500765 79159123
Coma 31.58 9.67 36 84464 100613 79559275
Respiratory acidosis 30.95 9.67 48 84452 11152 79648736
Neuromuscular block prolonged 30.77 9.67 17 84483 1013 79658875
Asthenia 30.73 9.67 734 83766 510955 79148933
Airway peak pressure increased 30.23 9.67 12 84488 334 79659554
Gene mutation 30.02 9.67 24 84476 2662 79657226
Small intestinal obstruction 29.36 9.67 79 84421 27193 79632695
Colitis 29.11 9.67 154 84346 73153 79586735
Hypersensitivity 29.09 9.67 161 84339 262078 79397810
Alopecia 29.09 9.67 136 84364 231219 79428669
Proctitis 29.09 9.67 35 84465 6397 79653491
Radiculopathy 28.96 9.67 41 84459 8783 79651105
Irritable bowel syndrome 28.76 9.67 15 84485 62226 79597662
Discomfort 28.66 9.67 56 84444 125561 79534327
Vaginal haemorrhage 28.50 9.67 68 84432 21749 79638139
Anhedonia 28.21 9.67 54 84446 14844 79645044
Drug ineffective 28.03 9.67 903 83597 1080010 78579878
COVID-19 27.48 9.67 81 84419 157593 79502295
Gastrointestinal disorder 26.58 9.67 56 84444 122149 79537739
Blood lactic acid increased 26.39 9.67 48 84452 12696 79647192
Lung hyperinflation 26.04 9.67 19 84481 1840 79658048
Oxygen saturation abnormal 25.92 9.67 28 84472 4554 79655334
Therapy cessation 25.75 9.67 93 84407 37469 79622419
Emotional distress 24.93 9.67 96 84404 39873 79620015
Fall 24.72 9.67 684 83816 486945 79172943
Sopor 24.62 9.67 3 84497 33007 79626881
Renal injury 24.57 9.67 55 84445 16872 79643016
Blood magnesium increased 24.49 9.67 24 84476 3482 79656406
Full blood count decreased 24.30 9.67 73 84427 26746 79633142
Urticaria thermal 24.12 9.67 11 84489 434 79659454
Maternal exposure during delivery 24.11 9.67 16 84484 1330 79658558
Device dislocation 23.83 9.67 71 84429 25899 79633989
Premature labour 23.24 9.67 36 84464 8354 79651534
Caesarean section 23.20 9.67 45 84455 12490 79647398
Pleocytosis 23.14 9.67 16 84484 1423 79658465
Status asthmaticus 22.76 9.67 14 84486 1020 79658868
Administration site erythema 22.76 9.67 10 84490 361 79659527
Muscle spasms 22.71 9.67 284 84216 174446 79485442
C-reactive protein increased 22.68 9.67 66 84434 128961 79530927
Blister 22.58 9.67 59 84441 119417 79540471
Injury 22.52 9.67 150 84350 77346 79582542
Rhabdomyolysis 21.81 9.67 48 84452 103083 79556805
Neuromuscular blockade 21.35 9.67 11 84489 569 79659319
Musculoskeletal stiffness 21.33 9.67 104 84396 174904 79484984
Fibromyalgia 21.31 9.67 22 84478 64318 79595570
Blood pressure fluctuation 21.08 9.67 24 84476 67121 79592767
Chills 21.06 9.67 261 84239 159973 79499915
Blood albumin decreased 21.04 9.67 65 84435 24178 79635710
Encephalopathy 20.52 9.67 132 84368 67265 79592623
Rheumatic fever 20.30 9.67 3 84497 28522 79631366
Platelet count decreased 20.23 9.67 304 84196 194360 79465528
Drug hypersensitivity 20.09 9.67 211 84289 298705 79361183
Nausea 19.83 9.67 1220 83280 955976 78703912
Atrial fibrillation 19.78 9.67 307 84193 197579 79462309
Haemoglobin decreased 19.75 9.67 338 84162 221781 79438107
Diabetes mellitus 19.62 9.67 33 84467 78357 79581531
Type 2 diabetes mellitus 19.52 9.67 19 84481 57103 79602785
Hypokalaemia 19.52 9.67 236 84264 143804 79516084
Swelling 19.43 9.67 142 84358 216569 79443319
Pulmonary hypertension 19.08 9.67 101 84399 47979 79611909
Mobility decreased 19.02 9.67 66 84434 122109 79537779
Anxiety 18.56 9.67 368 84132 248144 79411744
Electrocardiogram QT prolonged 18.42 9.67 161 84339 90225 79569663
Nasopharyngitis 18.40 9.67 176 84324 253705 79406183
Dizziness 18.27 9.67 706 83794 525735 79134153
Abdominal pain 18.21 9.67 541 83959 389028 79270860
Pantoea agglomerans infection 18.21 9.67 6 84494 96 79659792
Myelosuppression 18.19 9.67 10 84490 40286 79619602
Respiratory tract infection bacterial 17.94 9.67 16 84484 2061 79657827
Intentional self-injury 17.89 9.67 6 84494 32413 79627475
Dyspepsia 17.88 9.67 185 84315 108502 79551386
Normal newborn 17.74 9.67 29 84471 7043 79652845
Osteonecrosis of jaw 17.74 9.67 12 84488 43214 79616674
Small for dates baby 17.44 9.67 9 84491 467 79659421
Constipation 17.24 9.67 407 84093 282643 79377245
Ill-defined disorder 17.17 9.67 27 84473 65848 79594040
Pleural effusion 17.14 9.67 232 84268 145030 79514858
Metabolic encephalopathy 17.13 9.67 33 84467 9114 79650774
Pelvic pain 16.72 9.67 41 84459 13340 79646548
Hospice care 16.65 9.67 35 84465 10289 79649599
PO2 decreased 16.57 9.67 18 84482 2945 79656943
Agranulocytosis 16.56 9.67 14 84486 45016 79614872
Frequent bowel movements 16.07 9.67 68 84432 29471 79630417
Red blood cell sedimentation rate increased 16.03 9.67 15 84485 45927 79613961
Cytomegalovirus infection 16.00 9.67 13 84487 42631 79617257
Febrile neutropenia 15.90 9.67 338 84162 230661 79429227
Inflammation 15.73 9.67 49 84451 93704 79566184
Nail bed tenderness 15.67 9.67 8 84492 406 79659482
Vulvovaginal swelling 15.65 9.67 8 84492 407 79659481
Vitamin B6 increased 15.65 9.67 4 84496 24 79659864
Neuropathy peripheral 15.59 9.67 223 84277 141082 79518806
Weight increased 15.47 9.67 204 84296 277182 79382706
Labelled drug-drug interaction medication error 15.46 9.67 5 84495 27645 79632243
Endometritis 15.44 9.67 10 84490 798 79659090
Accidental exposure to product 15.30 9.67 7 84493 31315 79628573
Impaired healing 15.29 9.67 45 84455 87610 79572278
Drug reaction with eosinophilia and systemic symptoms 15.21 9.67 28 84472 64216 79595672
Bacteraemia 15.18 9.67 72 84428 32752 79627136
Blood pressure systolic increased 15.15 9.67 30 84470 66956 79592932
Torsade de pointes 15.14 9.67 50 84450 19262 79640626
Flatulence 15.11 9.67 87 84413 42637 79617251
Unresponsive to stimuli 15.03 9.67 106 84394 55682 79604206
Hepatic cytolysis 15.02 9.67 5 84495 27146 79632742
Abdominal discomfort 14.87 9.67 182 84318 250545 79409343
Interstitial lung disease 14.85 9.67 65 84435 112535 79547353
Hypocalcaemia 14.72 9.67 97 84403 49827 79610061
Colitis ulcerative 14.49 9.67 74 84426 34668 79625220
Atelectasis 14.37 9.67 70 84430 32187 79627701
Product contamination microbial 14.01 9.67 10 84490 936 79658952
Transfusion 13.93 9.67 52 84448 21278 79638610
Obstructive airways disorder 13.92 9.67 8 84492 31451 79628437
Asthma 13.87 9.67 85 84415 135010 79524878
Loss of personal independence in daily activities 13.66 9.67 59 84441 102521 79557367
Cellulitis 13.62 9.67 176 84324 108884 79551004
Anorgasmia 13.58 9.67 11 84489 1243 79658645
Epilepsy 13.50 9.67 14 84486 40846 79619042
Flushing 13.47 9.67 148 84352 88120 79571768
Failure to thrive 13.45 9.67 35 84465 11809 79648079
Complication associated with device 13.45 9.67 45 84455 17451 79642437
Aspartate aminotransferase increased 13.44 9.67 214 84286 138427 79521461
Fatigue 13.40 9.67 1151 83349 928576 78731312
Eosinophilia 13.39 9.67 17 84483 45328 79614560
Postpartum haemorrhage 13.21 9.67 12 84488 1583 79658305
Burkholderia test positive 13.08 9.67 8 84492 577 79659311
HELLP syndrome 13.05 9.67 9 84491 797 79659091
Drug-induced liver injury 12.99 9.67 32 84468 66085 79593803
Haematocrit decreased 12.90 9.67 110 84390 61202 79598686
Product complaint 12.73 9.67 37 84463 13312 79646576
Drug resistance 12.29 9.67 16 84484 42197 79617691
Bursitis 12.16 9.67 12 84488 35832 79624056
Grip strength decreased 12.15 9.67 4 84496 21865 79638023
Incision site pain 12.15 9.67 15 84485 2815 79657073
Mixed dementia 12.12 9.67 6 84494 285 79659603
Behaviour disorder 12.10 9.67 23 84477 6290 79653598
Pneumocystis jirovecii pneumonia 12.08 9.67 10 84490 32498 79627390
Macroglossia 12.04 9.67 10 84490 1171 79658717
Product prescribing error 12.03 9.67 18 84482 44795 79615093
Dyspnoea 12.03 9.67 1059 83441 855966 78803922
Dizziness postural 11.98 9.67 33 84467 11516 79648372
Electroencephalogram abnormal 11.93 9.67 21 84479 5413 79654475
Antinuclear antibody positive 11.86 9.67 26 84474 7864 79652024
Carbohydrate antigen 125 increased 11.75 9.67 13 84487 2171 79657717
Apnoea 11.70 9.67 33 84467 11671 79648217
Infection 11.64 9.67 183 84317 241529 79418359
White blood cell count decreased 11.53 9.67 271 84229 188017 79471871
Product contamination 11.47 9.67 10 84490 1250 79658638
Joint range of motion decreased 11.46 9.67 11 84489 33271 79626617
Wrong technique in product usage process 11.43 9.67 40 84460 73835 79586053
Prescribed overdose 11.40 9.67 14 84486 37869 79622019
Muscular weakness 11.32 9.67 236 84264 160493 79499395
Rectal haemorrhage 11.22 9.67 127 84373 76173 79583715
Tachypnoea 11.15 9.67 65 84435 31998 79627890
Fluid retention 11.09 9.67 118 84382 69691 79590197
Anaemia 11.06 9.67 577 83923 444438 79215450
Urine output decreased 11.00 9.67 43 84457 17979 79641909
Stillbirth 11.00 9.67 17 84483 3938 79655950
Hip arthroplasty 10.99 9.67 13 84487 35743 79624145
Hyporeflexia 10.86 9.67 16 84484 3552 79656336
Hypercapnia 10.76 9.67 27 84473 8908 79650980
Splenic vein thrombosis 10.72 9.67 8 84492 802 79659086
Ureteric stenosis 10.62 9.67 10 84490 1382 79658506
Hip fracture 10.46 9.67 62 84438 30699 79629189
Sinus tachycardia 10.45 9.67 71 84429 36837 79623051
Hypophagia 10.41 9.67 83 84417 45284 79614604
Blood pressure diastolic decreased 10.38 9.67 10 84490 30206 79629682
Impaired work ability 10.25 9.67 4 84496 19677 79640211
Pulmonary embolism 10.19 9.67 246 84254 171408 79488480
Pulmonary arterial hypertension 10.19 9.67 58 84442 28308 79631580
Laryngeal pain 10.18 9.67 21 84479 6093 79653795
Hepatitis 10.16 9.67 28 84472 55699 79604189
Wound drainage 10.11 9.67 9 84491 1157 79658731
Respiratory tract infection viral 10.06 9.67 17 84483 4242 79655646
Rheumatoid nodule 10.03 9.67 3 84497 17435 79642453
Therapy partial responder 9.99 9.67 3 84497 17394 79642494
Suspected transmission of an infectious agent via product 9.98 9.67 9 84491 1177 79658711
Liver injury 9.92 9.67 29 84471 56585 79603303
Enterococcal bacteraemia 9.69 9.67 14 84486 3054 79656834

FDA Adverse Event Reporting System (Pediatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Product preparation error 36.31 31.69 10 90 83 89609

Pharmacologic Action:

SourceCodeDescription
ATC A06AD04 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR CONSTIPATION
DRUGS FOR CONSTIPATION
Osmotically acting laxatives
ATC A12CC02 ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
OTHER MINERAL SUPPLEMENTS
Magnesium
ATC B05XA05 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
I.V. SOLUTION ADDITIVES
Electrolyte solutions
ATC D11AX05 DERMATOLOGICALS
OTHER DERMATOLOGICAL PREPARATIONS
OTHER DERMATOLOGICAL PREPARATIONS
Other dermatologicals
ATC V04CC02 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for bile duct patency
MeSH PA D000700 Analgesics
MeSH PA D000777 Anesthetics
MeSH PA D000889 Anti-Arrhythmia Agents
MeSH PA D000927 Anticonvulsants
MeSH PA D002121 Calcium Channel Blockers
MeSH PA D000077264 Calcium-Regulating Hormones and Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D049990 Membrane Transport Modulators
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D012102 Reproductive Control Agents
MeSH PA D018689 Sensory System Agents
MeSH PA D015149 Tocolytic Agents
CHEBI has role CHEBI:50503 laxante
CHEBI has role CHEBI:75325 cathartics
CHEBI has role CHEBI:33287 fertilizers
CHEBI has role CHEBI:35554 cardiovascular agent
CHEBI has role CHEBI:35623 anticonvulsants
CHEBI has role CHEBI:38070 antiarrhythmic agent
CHEBI has role CHEBI:38215 calcium channel blockers
CHEBI has role CHEBI:38867 anaesthetic
CHEBI has role CHEBI:66993 tocolytic drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Constipation indication 14760008 DOID:2089
Mild pre-eclampsia indication 41114007
Severe pre-eclampsia indication 46764007
Hypomagnesemia indication 190855004
Eclampsia in pregnancy indication 198992004
Incomplete passage of stool indication 249515001
Torsades de pointes off-label use 31722008
Atypical Ventricular Tachycardia off-label use
Hypocalcemia contraindication 5291005
Hyperkalemia contraindication 14140009
Complete atrioventricular block contraindication 27885002
Dehydration contraindication 34095006
Gastrointestinal ulcer contraindication 40845000
Congenital myotonia, autosomal dominant form contraindication 57938005
Acute nephropathy contraindication 58574008
Hypermagnesemia contraindication 66978005
Appendicitis contraindication 74400008 DOID:8337
Kidney disease contraindication 90708001 DOID:557
Gastrointestinal obstruction contraindication 126765001
Gastroparesis contraindication 235675006
Chronic diarrhea contraindication 236071009
Hyporeninemic hypoaldosteronism contraindication 236464008
Familial hyperkalemic periodic paralysis contraindication 304737009 DOID:14451
Severe dehydration contraindication 450316000




🐶 Veterinary Drug Use

SpeciesUseRelation
Cattles Used with sedative-relaxant and general anesthesia agents Indication
Horses Used with sedative-relaxant and general anesthesia agents Indication

🐶 Veterinary products

ProductApplicantIngredients
Chloropent Zoetis Inc. 3

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT SUPREP BOWEL PREP KIT BRAINTREE LABS N022372 Aug. 5, 2010 RX SOLUTION ORAL 6946149 March 7, 2023 GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS
0.225GM;0.188GM;1.479GM SUTAB BRAINTREE LABS N213135 Nov. 10, 2020 RX TABLET ORAL 11033498 Aug. 4, 2037 GASTROINTESTINAL TABLETS INDICATED FOR CLEANSING THE COLON IN PREPARATION FOR COLONOSCOPY
0.225GM;0.188GM;1.479GM SUTAB BRAINTREE LABS N213135 Nov. 10, 2020 RX TABLET ORAL 11382864 Aug. 4, 2037 GASTROINTESTINAL TABLETS INDICATED FOR CLEANSING THE COLON IN PREPARATION FOR COLONOSCOPY

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE NOVEL LABS INC A202511 Feb. 23, 2017 RX SOLUTION ORAL March 6, 2023 PATENT CHALLENGE
0.225GM;0.188GM;1.479GM SUTAB BRAINTREE LABS N213135 Nov. 10, 2020 RX TABLET ORAL Nov. 10, 2023 NEW PRODUCT
0.9GM/BOT;178.7GM/BOT;1.12GM/BOT;0.5GM/BOT;7.3GM/BOT SUFLAVE BRAINTREE LABS N215344 June 15, 2023 RX FOR SOLUTION ORAL June 15, 2026 NEW PRODUCT
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT SUPREP BOWEL PREP KIT BRAINTREE LABS N022372 Aug. 5, 2010 RX SOLUTION ORAL Aug. 5, 2027 FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER

Bioactivity Summary:

None

External reference:

IDSource
4019181 VUID
N0000147424 NUI
10034-99-8 SECONDARY_CAS_RN
4000969 VANDF
4017468 VANDF
4017680 VANDF
4019181 VANDF
C0024480 UMLSCUI
CHEBI:32599 CHEBI
CHEMBL2021423 ChEMBL_ID
CHEMBL3989857 ChEMBL_ID
D008278 MESH_DESCRIPTOR_UI
DB00653 DRUGBANK_ID
24083 PUBCHEM_CID
1053346 RXNORM
173828 MMSL
173829 MMSL
26390 MMSL
36335 MMSL
5017 MMSL
5259 MMSL
6287 MMSL
7114 MMSL
d00468 MMSL
000789 NDDF
001184 NDDF
003022 NDDF
006708 NDDF
1269139001 SNOMEDCT_US
37400007 SNOMEDCT_US
387202002 SNOMEDCT_US
725797001 SNOMEDCT_US
SK47B8698T UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4204 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4204 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4205 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4205 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4206 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Water HUMAN PRESCRIPTION DRUG LABEL 1 0264-4206 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 21 sections
Magnesium Sulfate in Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-4400 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 26 sections
TIS-U-SOL HUMAN PRESCRIPTION DRUG LABEL 5 0338-0190 IRRIGANT 20 mg IRRIGATION NDA 5 sections
TIS-U-SOL HUMAN PRESCRIPTION DRUG LABEL 5 0338-0190 IRRIGANT 20 mg IRRIGATION NDA 5 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1708 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1708 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1708 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1708 INJECTION, SOLUTION 2 g INTRAVENOUS ANDA 20 sections
MAGNESIUM SULFATE IN DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-1709 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 23 sections
MAGNESIUM SULFATE IN DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-1709 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 23 sections
MAGNESIUM SULFATE IN DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-1709 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 23 sections
MAGNESIUM SULFATE IN DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-1709 INJECTION, SOLUTION 10 mg INTRAVENOUS ANDA 23 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1715 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1715 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1715 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1715 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1719 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1719 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1719 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Magnesium Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 0338-1719 INJECTION, SOLUTION 4 g INTRAVENOUS ANDA 20 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 0363-0395 GRANULE 1 g ORAL OTC monograph not final 15 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 0363-0942 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 15 sections
Epsom Salt HUMAN OTC DRUG LABEL 1 0363-0942 GRANULE, FOR SOLUTION 1 g ORAL OTC monograph not final 15 sections
Humco Epson Salt HUMAN OTC DRUG LABEL 1 0395-0807 POWDER, FOR SOLUTION 1000 mg ORAL OTC monograph not final 10 sections
Humco Epson Salt HUMAN OTC DRUG LABEL 1 0395-0807 POWDER, FOR SOLUTION 1000 mg ORAL OTC monograph not final 10 sections